COVID-19: biological factors in men’s vulnerability
The current COVID-19 outbreak has raised many questions, in particular the disproportionately higher number of deaths among men compared with women.
Due to the severity of the pandemic, a vast (and often confusing) amount of information has rapidly been published on the subject – yet our understanding may not be clear for some time.
In this webinar, published early due to its relevance, our key experts distil through the recent studies to bring you vital information on the biological explanations for why men seem to succumb more readily to the virus’ deadly effects. Key themes discussed include: an overview of recent statistics of COVID-19 in men; the ACE2 receptor and its relationship with the virus; and the the role of testosterone, endothelial dysfunction and the male immune system on the severity of COVID-19 infection.
Please submit any questions to the comments field below, and feel free to begin a discussion on some of the points raised.
Emeritus Professor Alan White
Leeds Beckett University (retired)
Professor Mike Kirby
Editor, Trends in Urology and Men’s Health
Dr Patricia Schartau
GP and Academic Clinical Lecturer
Hampstead Group Practice and University College London
- COVID-19 in men: what we know so far – Alan White
- COVID-19 and the ACE2 receptor – Patricia Shartau
- Testosterone and COVID-19 – Mike Kirby
- COVID-19 and the immune system – Alan White
- Q&A – All
Male mortality and the German response: lessons from COVID-19
The current COVID-19 outbreak has raised many questions, amongst them the higher mortality rates in men and the low overall mortality rates in Germany compared to other European countries. Here the authors explore some of the reasons behind both these phenomena and outline what we can learn from them for the future.
COVID-19: providing support for men with prostate cancer
Men with prostate cancer are understandably worried about the impact of COVID-19 on their care. Prostate Cancer UK is helping to provide support and reassurance but the authors warn that men with prostate cancer must not be forgotten in the efforts to rebuild services after the threat of COVID-19 becomes less pressing.
Research and urology at a time of COVID-19
COVID-19 has brought a lot of medical research and surgical training to a halt. Here the author investigates the impact of the suspension on the future of patient-centred research and the career prospects of healthcare professionals, along with an insider insight into the work at the NHS Nightingale, London.